Paradigm Changes in Prostate Cancer Management in Recent Years

Exploring Recent Developments in The Treatment of Prostate Cancer

Jack Andrews, MD; Alicia Morgans, MD, MPH; and Ashley Ross MD, PhD, discuss how trial design, inclusion criteria, and end points like radiographic progression-free survival vs overall survival impact clinical decision-making in prostate cancer treatment, emphasizing the importance of quality of life data and the shift from using ADT alone as standard care toward combination therapies in prostate cancer management.

Paradigm Changes in Prostate Cancer Management in Recent Years

This article discusses changes in the advanced prostate cancer landscape over the past decade that have induced a paradigm shift in...